Medicure MCUJF
OTC MCUJF
$0.93 +0.08 (+9.41%)
As of: Aug 21, 2026 · 3:18 PM EDT

Medicure (MCUJF) Cash from Discontinued Operations (2009 - 2025)

Medicure (MCUJF) posted quarterly Cash from Discontinued Operations of 377123.57 for Q3 2025, up 33.19% year-over-year from 283152.24 in Q3 2024, and up 33.19% quarter-over-quarter from 564451.13 in Q3 2024.

Medicure (MCUJF) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends

Medicure's Cash from Discontinued Operations history runs 6 years deep, the most recent figure standing at 377123.57 for Q3 2025.

  • In Q3 2025, Cash from Discontinued Operations rose 33.19% year-over-year to 377123.57; the TTM figure through Sep 2025 stood at 806633.99 (down 509.98% YoY), while the FY2016 annual figure was 20228745.63, changed N/A from the prior year.
  • Cash from Discontinued Operations for Q3 2025 stood at 377123.57, up from 564451.13 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 377123.57 in Q3 2025, with the low at 564451.13 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Medicure 97.06 Mn 95.93 Mn 2.57 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -377,123.57
Sep 30, 2025 -377,123.57
Sep 30, 2024 -564,451.13
Sep 30, 2024 -564,451.13
Sep 30, 2017 -168,683.19
Sep 30, 2017 -168,683.19
Feb 28, 2011 303,623.90
Feb 28, 2011 303,623.90
Feb 28, 2010 297,270.86
Feb 28, 2010 297,270.86
Feb 28, 2009 2.98 Mn
Feb 28, 2009 2.98 Mn